|  Help  |  About  |  Contact Us

Search our database by keyword

- or -

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 701 to 800 out of 1170 for Erbb2

Category restricted to Publication (x)

0.037s

Categories

Category: Publication
Type Details Score
Publication
First Author: La Merrill M
Year: 2009
Journal: Am J Physiol Endocrinol Metab
Title: Mouse breast cancer model-dependent changes in metabolic syndrome-associated phenotypes caused by maternal dioxin exposure and dietary fat.
Volume: 296
Issue: 1
Pages: E203-10
Publication
First Author: Youngblood VM
Year: 2016
Journal: Cancer Res
Title: The Ephrin-A1/EPHA2 Signaling Axis Regulates Glutamine Metabolism in HER2-Positive Breast Cancer.
Volume: 76
Issue: 7
Pages: 1825-36
Publication
First Author: Hannesdóttir L
Year: 2013
Journal: Eur J Immunol
Title: Lapatinib and doxorubicin enhance the Stat1-dependent antitumor immune response.
Volume: 43
Issue: 10
Pages: 2718-29
Publication
First Author: Rennhack JP
Year: 2019
Journal: Nat Commun
Title: Integrated analyses of murine breast cancer models reveal critical parallels with human disease.
Volume: 10
Issue: 1
Pages: 3261
Publication
First Author: Heckman-Stoddard BM
Year: 2009
Journal: Breast Cancer Res
Title: Haploinsufficiency for p190B RhoGAP inhibits MMTV-Neu tumor progression.
Volume: 11
Issue: 4
Pages: R61
Publication
First Author: Boggio K
Year: 2000
Journal: Cancer Res
Title: Ability of systemic interleukin-12 to hamper progressive stages of mammary carcinogenesis in HER2/neu transgenic mice.
Volume: 60
Issue: 2
Pages: 359-64
Publication
First Author: Di Carlo E
Year: 1999
Journal: Lab Invest
Title: Analysis of mammary carcinoma onset and progression in HER-2/neu oncogene transgenic mice reveals a lobular origin.
Volume: 79
Issue: 10
Pages: 1261-9
Publication
First Author: Quaglino E
Year: 2010
Journal: Cancer Res
Title: A better immune reaction to Erbb-2 tumors is elicited in mice by DNA vaccines encoding rat/human chimeric proteins.
Volume: 70
Issue: 7
Pages: 2604-12
Publication
First Author: Srijakotre N
Year: 2020
Journal: Proc Natl Acad Sci U S A
Title: PtdIns(3,4,5)P3-dependent Rac exchanger 1 (P-Rex1) promotes mammary tumor initiation and metastasis.
Volume: 117
Issue: 45
Pages: 28056-28067
Publication
First Author: Rudolph-Owen LA
Year: 1998
Journal: Cancer Res
Title: The matrix metalloproteinase matrilysin influences early-stage mammary tumorigenesis.
Volume: 58
Issue: 23
Pages: 5500-6
Publication
First Author: De Lorenzo MS
Year: 2014
Journal: Aging Cell
Title: 'Reduced malignancy as a mechanism for longevity in mice with adenylyl cyclase type 5 disruption'.
Volume: 13
Issue: 1
Pages: 102-10
Publication
First Author: Hannesdóttir L
Year: 2012
Journal: Int J Dev Biol
Title: MMTV-neu mice deficient in STAT1 are susceptible to develop ovarian teratomas.
Volume: 56
Issue: 4
Pages: 279-83
Publication
First Author: Balamurugan K
Year: 2010
Journal: EMBO J
Title: The tumour suppressor C/EBPδ inhibits FBXW7 expression and promotes mammary tumour metastasis.
Volume: 29
Issue: 24
Pages: 4106-17
Publication
First Author: Lenferink AE
Year: 2000
Journal: Proc Natl Acad Sci U S A
Title: Blockade of the epidermal growth factor receptor tyrosine kinase suppresses tumorigenesis in MMTV/Neu + MMTV/TGF-alpha bigenic mice.
Volume: 97
Issue: 17
Pages: 9609-14
Publication
First Author: Cardiff RD
Year: 1995
Journal: Cancer Lett
Title: Comparative pathology of mammary tumorigenesis in transgenic mice.
Volume: 90
Issue: 1
Pages: 13-9
Publication
First Author: Laine A
Year: 2013
Journal: Cancer Discov
Title: Senescence sensitivity of breast cancer cells is defined by positive feedback loop between CIP2A and E2F1.
Volume: 3
Issue: 2
Pages: 182-97
Publication
First Author: Lee S
Year: 2018
Journal: Oncogene
Title: Na+,HCO3--cotransporter NBCn1 (Slc4a7) accelerates ErbB2-induced breast cancer development and tumor growth in mice.
Volume: 37
Issue: 41
Pages: 5569-5584
Publication
First Author: Chiodoni C
Year: 2006
Journal: J Exp Med
Title: Triggering CD40 on endothelial cells contributes to tumor growth.
Volume: 203
Issue: 11
Pages: 2441-50
Publication
First Author: Ritland SR
Year: 1997
Journal: Cancer Res
Title: Loss of heterozygosity analysis in primary mammary tumors and lung metastases of MMTV-MTAg and MMTV-neu transgenic mice.
Volume: 57
Issue: 16
Pages: 3520-5
Publication
First Author: Little JL
Year: 2014
Journal: Oncogene
Title: A requirement for Nedd9 in luminal progenitor cells prior to mammary tumorigenesis in MMTV-HER2/ErbB2 mice.
Volume: 33
Issue: 4
Pages: 411-20
Publication
First Author: Hüsemann Y
Year: 2008
Journal: Cancer Cell
Title: Systemic spread is an early step in breast cancer.
Volume: 13
Issue: 1
Pages: 58-68
Publication
First Author: Saha A
Year: 2010
Journal: Cell Immunol
Title: Dendritic cells pulsed with an anti-idiotype antibody mimicking Her-2/neu induced protective antitumor immunity in two lines of Her-2/neu transgenic mice.
Volume: 263
Issue: 1
Pages: 9-21
Publication  
First Author: Balamurugan K
Year: 2013
Journal: Nat Commun
Title: FBXW7α attenuates inflammatory signalling by downregulating C/EBPδ and its target gene Tlr4.
Volume: 4
Pages: 1662
Publication
First Author: Nørgaard P
Year: 1999
Journal: Clin Cancer Res
Title: Treatment with farnesyl-protein transferase inhibitor induces regression of mammary tumors in transforming growth factor (TGF) alpha and TGF alpha/neu transgenic mice by inhibition of mitogenic activity and induction of apoptosis.
Volume: 5
Issue: 1
Pages: 35-42
Publication
First Author: Boggio K
Year: 1998
Journal: J Exp Med
Title: Interleukin 12-mediated prevention of spontaneous mammary adenocarcinomas in two lines of Her-2/neu transgenic mice.
Volume: 188
Issue: 3
Pages: 589-96
Publication
First Author: Yang Y
Year: 2021
Journal: Cell Rep
Title: Functional cooperation between co-amplified genes promotes aggressive phenotypes of HER2-positive breast cancer.
Volume: 34
Issue: 10
Pages: 108822
Publication
First Author: Taneja P
Year: 2010
Journal: Cancer Res
Title: Critical roles of DMP1 in human epidermal growth factor receptor 2/neu-Arf-p53 signaling and breast cancer development.
Volume: 70
Issue: 22
Pages: 9084-94
Publication
First Author: Kim S
Year: 2012
Journal: PLoS One
Title: A phenotypic mouse model of basaloid breast tumors.
Volume: 7
Issue: 2
Pages: e30979
Publication
First Author: Asrani K
Year: 2013
Journal: Mol Cancer Res
Title: The HER2- and heregulin β1 (HRG)-inducible TNFR superfamily member Fn14 promotes HRG-driven breast cancer cell migration, invasion, and MMP9 expression.
Volume: 11
Issue: 4
Pages: 393-404
Publication
First Author: Niemeyer CC
Year: 1999
Journal: Int J Cancer
Title: Preneoplastic mammary tumor markers: Cripto and Amphiregulin are overexpressed in hyperplastic stages of tumor progression in transgenic mice.
Volume: 81
Issue: 4
Pages: 588-91
Publication
First Author: Tracey N
Year: 2020
Journal: Breast Cancer Res Treat
Title: HO-1 drives autophagy as a mechanism of resistance against HER2-targeted therapies.
Volume: 179
Issue: 3
Pages: 543-555
Publication
First Author: Levi L
Year: 2013
Journal: Cancer Res
Title: Genetic ablation of the fatty acid-binding protein FABP5 suppresses HER2-induced mammary tumorigenesis.
Volume: 73
Issue: 15
Pages: 4770-80
Publication
First Author: Miller AV
Year: 2013
Journal: PLoS One
Title: Paclitaxel-induced apoptosis is BAK-dependent, but BAX and BIM-independent in breast tumor.
Volume: 8
Issue: 4
Pages: e60685
Publication
First Author: Lehembre F
Year: 2008
Journal: EMBO J
Title: NCAM-induced focal adhesion assembly: a functional switch upon loss of E-cadherin.
Volume: 27
Issue: 19
Pages: 2603-15
Publication
First Author: Leng X
Year: 2009
Journal: Cancer Res
Title: Inhibition of lipocalin 2 impairs breast tumorigenesis and metastasis.
Volume: 69
Issue: 22
Pages: 8579-84
Publication  
First Author: Deblois G
Year: 2016
Journal: Nat Commun
Title: ERRα mediates metabolic adaptations driving lapatinib resistance in breast cancer.
Volume: 7
Pages: 12156
Publication
First Author: Jacob JB
Year: 2023
Journal: iScience
Title: Identification of actionable targets for breast cancer intervention using a diversity outbred mouse model.
Volume: 26
Issue: 4
Pages: 106320
Publication
First Author: Huo Y
Year: 2016
Journal: Cell Rep
Title: An In Vivo Gain-of-Function Screen Identifies the Williams-Beuren Syndrome Gene GTF2IRD1 as a Mammary Tumor Promoter.
Volume: 15
Issue: 10
Pages: 2089-2096
Publication
First Author: Huang P
Year: 2024
Journal: Cell Host Microbe
Title: Peptostreptococcus stomatis promotes colonic tumorigenesis and receptor tyrosine kinase inhibitor resistance by activating ERBB2-MAPK.
Volume: 32
Issue: 8
Pages: 1365-1379.e10
Publication
First Author: He J
Year: 2023
Journal: Sci Adv
Title: Inactivation of the tumor suppressor gene Apc synergizes with H. pylori to induce DNA damage in murine gastric stem and progenitor cells.
Volume: 9
Issue: 46
Pages: eadh0322
Publication
First Author: Grossmann KS
Year: 2009
Journal: Proc Natl Acad Sci U S A
Title: The tyrosine phosphatase Shp2 (PTPN11) directs Neuregulin-1/ErbB signaling throughout Schwann cell development.
Volume: 106
Issue: 39
Pages: 16704-9
Publication
First Author: Muta Y
Year: 2018
Journal: Nat Commun
Title: Composite regulation of ERK activity dynamics underlying tumour-specific traits in the intestine.
Volume: 9
Issue: 1
Pages: 2174
Publication
First Author: Meyer D
Year: 1995
Journal: Nature
Title: Multiple essential functions of neuregulin in development.
Volume: 378
Issue: 6555
Pages: 386-90
Publication
First Author: Fledrich R
Year: 2019
Journal: Nat Commun
Title: NRG1 type I dependent autoparacrine stimulation of Schwann cells in onion bulbs of peripheral neuropathies.
Volume: 10
Issue: 1
Pages: 1467
Publication
First Author: Miyabayashi K
Year: 2013
Journal: Cancer Res
Title: Erlotinib prolongs survival in pancreatic cancer by blocking gemcitabine-induced MAPK signals.
Volume: 73
Issue: 7
Pages: 2221-34
Publication
First Author: Kelber JA
Year: 2012
Journal: Cancer Res
Title: KRas induces a Src/PEAK1/ErbB2 kinase amplification loop that drives metastatic growth and therapy resistance in pancreatic cancer.
Volume: 72
Issue: 10
Pages: 2554-64
Publication
First Author: Graveel CR
Year: 2009
Journal: Proc Natl Acad Sci U S A
Title: Met induces diverse mammary carcinomas in mice and is associated with human basal breast cancer.
Volume: 106
Issue: 31
Pages: 12909-14
Publication
First Author: Lim EF
Year: 2017
Journal: Proc Natl Acad Sci U S A
Title: AlphaB-crystallin regulates remyelination after peripheral nerve injury.
Volume: 114
Issue: 9
Pages: E1707-E1716
Publication
First Author: Grove M
Year: 2007
Journal: J Cell Biol
Title: FAK is required for axonal sorting by Schwann cells.
Volume: 176
Issue: 3
Pages: 277-82
Publication
First Author: Ling C
Year: 2010
Journal: Genes Dev
Title: A novel role for 14-3-3sigma in regulating epithelial cell polarity.
Volume: 24
Issue: 9
Pages: 947-56
Publication
First Author: Allen T
Year: 2006
Journal: Cancer Res
Title: Grg1 acts as a lung-specific oncogene in a transgenic mouse model.
Volume: 66
Issue: 3
Pages: 1294-301
Publication
First Author: Willem M
Year: 2006
Journal: Science
Title: Control of peripheral nerve myelination by the beta-secretase BACE1.
Volume: 314
Issue: 5799
Pages: 664-6
Publication
First Author: Li D
Year: 2021
Journal: Cell Death Dis
Title: Oxytocin receptor induces mammary tumorigenesis through prolactin/p-STAT5 pathway.
Volume: 12
Issue: 6
Pages: 588
Publication  
First Author: Zhou C
Year: 2012
Journal: Mol Cancer
Title: Effect of cancer-associated mutations in the PlexinB1 gene.
Volume: 11
Pages: 11
Publication
First Author: Garratt AN
Year: 2000
Journal: Bioessays
Title: Neuregulin, a factor with many functions in the life of a schwann cell.
Volume: 22
Issue: 11
Pages: 987-96
Publication
First Author: Kraus MH
Year: 1989
Journal: Proc Natl Acad Sci U S A
Title: Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors.
Volume: 86
Issue: 23
Pages: 9193-7
Publication
First Author: Winqvist R
Year: 1990
Journal: Hum Genet
Title: The gene for 17 beta-hydroxysteroid dehydrogenase maps to human chromosome 17, bands q12-q21, and shows an RFLP with ScaI.
Volume: 85
Issue: 5
Pages: 473-6
Publication
First Author: Li BS
Year: 2003
Journal: J Biol Chem
Title: Cyclin-dependent kinase-5 is involved in neuregulin-dependent activation of phosphatidylinositol 3-kinase and Akt activity mediating neuronal survival.
Volume: 278
Issue: 37
Pages: 35702-9
Publication
First Author: Calogero RA
Year: 2008
Journal: Cancer Immunol Immunother
Title: Oncoantigens as anti-tumor vaccination targets: the chance of a lucky strike?
Volume: 57
Issue: 11
Pages: 1685-94
Publication
First Author: Cicalese A
Year: 2009
Journal: Cell
Title: The tumor suppressor p53 regulates polarity of self-renewing divisions in mammary stem cells.
Volume: 138
Issue: 6
Pages: 1083-95
Publication
First Author: Jiao X
Year: 2010
Journal: J Biol Chem
Title: c-Jun induces mammary epithelial cellular invasion and breast cancer stem cell expansion.
Volume: 285
Issue: 11
Pages: 8218-26
Publication
First Author: Xue B
Year: 2013
Journal: Nat Cell Biol
Title: Loss of Par3 promotes breast cancer metastasis by compromising cell-cell cohesion.
Volume: 15
Issue: 2
Pages: 189-200
Publication
First Author: Cagnoni G
Year: 2014
Journal: Oncogene
Title: Semaphorin receptors meet receptor tyrosine kinases on the way of tumor progression.
Volume: 33
Issue: 40
Pages: 4795-802
Publication
First Author: Amson R
Year: 2011
Journal: Nat Med
Title: Reciprocal repression between P53 and TCTP.
Volume: 18
Issue: 1
Pages: 91-9
Publication
First Author: Han J
Year: 2023
Journal: Genes Dev
Title: Stromal-derived NRG1 enables oncogenic KRAS bypass in pancreas cancer.
Volume: 37
Issue: 17-18
Pages: 818-828
Publication
First Author: Lodato S
Year: 2014
Journal: Nat Neurosci
Title: Gene co-regulation by Fezf2 selects neurotransmitter identity and connectivity of corticospinal neurons.
Volume: 17
Issue: 8
Pages: 1046-54
Publication
First Author: Rosner A
Year: 2002
Journal: Am J Pathol
Title: Pathway pathology: histological differences between ErbB/Ras and Wnt pathway transgenic mammary tumors.
Volume: 161
Issue: 3
Pages: 1087-97
Publication
First Author: Thompson JA
Year: 1997
Journal: Int J Cancer
Title: Expression of transgenic carcinoembryonic antigen (CEA) in tumor-prone mice: an animal model for CEA-directed tumor immunotherapy.
Volume: 72
Issue: 1
Pages: 197-202
Publication
First Author: Erdman SE
Year: 2010
Journal: Int J Cancer
Title: Unifying roles for regulatory T cells and inflammation in cancer.
Volume: 126
Issue: 7
Pages: 1651-65
Publication
First Author: Chang H
Year: 2012
Journal: Dev Biol
Title: Mammary epithelial-restricted expression of activated c-src rescues the block to mammary gland morphogenesis due to the deletion of the C-terminus of Patched-1.
Volume: 370
Issue: 2
Pages: 187-97
Publication
First Author: Alexandrova EM
Year: 2017
Journal: Cell Death Dis
Title: p53 loss-of-heterozygosity is a necessary prerequisite for mutant p53 stabilization and gain-of-function in vivo.
Volume: 8
Issue: 3
Pages: e2661
Publication
First Author: Deng Q
Year: 2019
Journal: Nat Commun
Title: Tissue-specific microRNA expression alters cancer susceptibility conferred by a TP53 noncoding variant.
Volume: 10
Issue: 1
Pages: 5061
Publication
First Author: Pathania R
Year: 2016
Journal: Cancer Res
Title: Combined Inhibition of DNMT and HDAC Blocks the Tumorigenicity of Cancer Stem-like Cells and Attenuates Mammary Tumor Growth.
Volume: 76
Issue: 11
Pages: 3224-35
Publication
First Author: Zhang X
Year: 2010
Journal: Cancer Res
Title: Oncogenic Wip1 phosphatase is inhibited by miR-16 in the DNA damage signaling pathway.
Volume: 70
Issue: 18
Pages: 7176-86
Publication
First Author: Triulzi C
Year: 2010
Journal: Cancer Res
Title: Antibody-dependent natural killer cell-mediated cytotoxicity engendered by a kinase-inactive human HER2 adenovirus-based vaccination mediates resistance to breast tumors.
Volume: 70
Issue: 19
Pages: 7431-41
Publication
First Author: Quaglino E
Year: 2004
Journal: Cancer Res
Title: Electroporated DNA vaccine clears away multifocal mammary carcinomas in her-2/neu transgenic mice.
Volume: 64
Issue: 8
Pages: 2858-64
Publication
First Author: Howe LR
Year: 2005
Journal: Cancer Res
Title: HER2/neu-induced mammary tumorigenesis and angiogenesis are reduced in cyclooxygenase-2 knockout mice.
Volume: 65
Issue: 21
Pages: 10113-9
Publication
First Author: Borcherding N
Year: 2015
Journal: Cancer Res
Title: Paracrine WNT5A Signaling Inhibits Expansion of Tumor-Initiating Cells.
Volume: 75
Issue: 10
Pages: 1972-82
Publication
First Author: Brodie SG
Year: 2001
Journal: Oncogene
Title: Inactivation of p53 tumor suppressor gene acts synergistically with c-neu oncogene in salivary gland tumorigenesis.
Volume: 20
Issue: 12
Pages: 1445-54
Publication
First Author: Huang S
Year: 2005
Journal: Genome Biol
Title: Changes in gene expression during the development of mammary tumors in MMTV-Wnt-1 transgenic mice.
Volume: 6
Issue: 10
Pages: R84
Publication
First Author: Chen DY
Year: 2012
Journal: Cancer Res
Title: A pharmacologic inhibitor of the protease Taspase1 effectively inhibits breast and brain tumor growth.
Volume: 72
Issue: 3
Pages: 736-46
Publication
First Author: Wan L
Year: 2014
Journal: Cancer Cell
Title: MTDH-SND1 interaction is crucial for expansion and activity of tumor-initiating cells in diverse oncogene- and carcinogen-induced mammary tumors.
Volume: 26
Issue: 1
Pages: 92-105
Publication
First Author: Yan L
Year: 2011
Journal: PLoS One
Title: Activation of the canonical Wnt/β-catenin pathway in ATF3-induced mammary tumors.
Volume: 6
Issue: 1
Pages: e16515
Publication
First Author: Landis MD
Year: 2006
Journal: Oncogene
Title: Sustained trophism of the mammary gland is sufficient to accelerate and synchronize development of ErbB2/Neu-induced tumors.
Volume: 25
Issue: 23
Pages: 3325-34
Publication
First Author: Prokakis E
Year: 2021
Journal: Oncogene
Title: USP22 promotes HER2-driven mammary carcinoma aggressiveness by suppressing the unfolded protein response.
Volume: 40
Issue: 23
Pages: 4004-4018
Publication
First Author: Chanmee T
Year: 2014
Journal: J Biol Chem
Title: Excessive hyaluronan production promotes acquisition of cancer stem cell signatures through the coordinated regulation of Twist and the transforming growth factor β (TGF-β)-Snail signaling axis.
Volume: 289
Issue: 38
Pages: 26038-26056
Publication
First Author: Joshi S
Year: 2017
Journal: Am J Cancer Res
Title: 14-3-3ζ loss impedes oncogene-induced mammary tumorigenesis and metastasis by attenuating oncogenic signaling.
Volume: 7
Issue: 8
Pages: 1654-1664
Publication
First Author: Sloan EK
Year: 2009
Journal: Am J Pathol
Title: Stromal cell expression of caveolin-1 predicts outcome in breast cancer.
Volume: 174
Issue: 6
Pages: 2035-43
Publication
First Author: Zhang C
Year: 2010
Journal: Cancer Res
Title: Tip30 deletion in MMTV-Neu mice leads to enhanced EGFR signaling and development of estrogen receptor-positive and progesterone receptor-negative mammary tumors.
Volume: 70
Issue: 24
Pages: 10224-33
Publication
First Author: Parsons MJ
Year: 2013
Journal: Cell Death Differ
Title: Genetic deletion of caspase-2 accelerates MMTV/c-neu-driven mammary carcinogenesis in mice.
Volume: 20
Issue: 9
Pages: 1174-82
Publication
First Author: Wang Z
Year: 2017
Journal: Dev Cell
Title: Binding of PLD2-Generated Phosphatidic Acid to KIF5B Promotes MT1-MMP Surface Trafficking and Lung Metastasis of Mouse Breast Cancer Cells.
Volume: 43
Issue: 2
Pages: 186-197.e7
Publication
First Author: Cao J
Year: 2014
Journal: Cell Rep
Title: Histone demethylase RBP2 is critical for breast cancer progression and metastasis.
Volume: 6
Issue: 5
Pages: 868-77
Publication
First Author: Ciocca DR
Year: 2012
Journal: Histochem Cell Biol
Title: Absence of caveolin-1 alters heat shock protein expression in spontaneous mammary tumors driven by Her-2/neu expression.
Volume: 137
Issue: 2
Pages: 187-94
Publication
First Author: Uceda-Castro R
Year: 2022
Journal: Cell Rep Med
Title: Re-purposing the pro-senescence properties of doxorubicin to introduce immunotherapy in breast cancer brain metastasis.
Volume: 3
Issue: 11
Pages: 100821
Publication
First Author: Jones CE
Year: 2019
Journal: Neoplasia
Title: Stromal PTEN Regulates Extracellular Matrix Organization in the Mammary Gland.
Volume: 21
Issue: 1
Pages: 132-145
Publication
First Author: Fleming NI
Year: 2009
Journal: Cancer Res
Title: Parathyroid hormone-related protein protects against mammary tumor emergence and is associated with monocyte infiltration in ductal carcinoma in situ.
Volume: 69
Issue: 18
Pages: 7473-9
Publication
First Author: Wan R
Year: 2012
Journal: Int J Oncol
Title: Haploinsufficiency of the Nijmegen breakage syndrome 1 gene increases mammary tumor latency and metastasis.
Volume: 41
Issue: 1
Pages: 345-52
Publication
First Author: Ramirez NE
Year: 2011
Journal: J Clin Invest
Title: The α₂β₁ integrin is a metastasis suppressor in mouse models and human cancer.
Volume: 121
Issue: 1
Pages: 226-37
Publication
First Author: Taylor NA
Year: 2017
Journal: J Clin Invest
Title: Treg depletion potentiates checkpoint inhibition in claudin-low breast cancer.
Volume: 127
Issue: 9
Pages: 3472-3483
Publication
First Author: Park JM
Year: 2015
Journal: Oncogene
Title: The role of Tcfap2c in tumorigenesis and cancer growth in an activated Neu model of mammary carcinogenesis.
Volume: 34
Issue: 50
Pages: 6105-14